In a report published Thursday, Bank of America analyst Robert M. Willoughby reiterated a Buy rating on Cardinal Health CAH, and raised the price target from $75.00 to $76.00.
In the report, Bank of America noted, “CAH will acquire AccessClosure, a privately held manufacturer and distributor of extravascular closure devices in U.S. markets, for $320 million in cash (~4x $80 million in annual revenues). The transaction is expected to close by early June, subject to regulatory approval. We maintain our FY14 EPS estimate of $3.80 on a minimal expected near term earnings impact, but we are raising our FY15 estimate to $4.20 (from $4.15) on expected accretion. Our P.O. moves to $76 (from $75).”
Cardinal Health closed on Wednesday at $70.28.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in